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1. Introduction
  Colorectal cancer includes large bowel cancer (colon 
cancer) and cancer of the back passage (rectal cancer or 
cancer of the rectum), with higher morbidity and mortality. 
In recent years, its prevalence shows an upward trend 
year by year and the ratio of male to female is about 1:1[1]. 
Heat shock protein 90 (Hsp90) plays an important role 
in vascularization, invasion and metastasis of tumors, 
proliferation of tumor cells, time course of cell cycles, 
as well as the conformation, stability and function 
maintenance of several carcinogenic proteins involving in 
the signal transduction pathway of cell apoptosis[2]; while 
Hypoxia-inducible factor (HIF)-1a could regulate tumor 
angiogenesis, glycolysis and invasiveness of tumors[3-5]. 
In our study, we detected the expression levels of HSP90 
and HIF-1毩 by immunohistochemical SABC method in 
the colorectal cancer tissues, observed their relationships 
with the clinicopathologic features of colorectal cancer and 
explored their correlations, in order to investigate the effects 
of HSP90 and HIF-1毩 on the occurrence and development 
of colorectal cancer, as well as their roles in the invasion 
and metastasis process. 
2. Materials and methods
2.1. General data 
  Paraffin-embedded tissue samples between October 2012 
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and January 2004 and the fresh colorectal cancer tissues by 
surgical resection between October 2012 and January 2013 
were selected. None had radio- and chemotherapy before 
and all cases were verified by pathological examination 
after operation. 46 cases of colorectal adenocarcinoma were 
enrolled in total, including 28 male and 18 female patients. 
The median age was 60.5 (36-81) years. These 46 cases 
included 25 cased with colon cancer and 21 cases with 
rectal cancer; 29 cases with high and medium differentiated 
adenocarcinoma and 17 cases with poorly differentiated 
adenocarcinoma; 16 cases with lymphatic metastasis and 30 
cases  without lymphatic metastasis; 30 cases at Dukes A+B 
and 16 case at Dukes C+D in accordance with the Dukes’ 
stage. Meanwhile, 20 normal tissues were selected more than 
10 cm away from the site of the tumor as the control group. 
2.2. Primary reagents and methods 
  Mouse anti-human HSP90 monoclonal antibody (at 
a dilution of 1:100) and mouse anti-human HIF-1毩 
monoclonal antibody (1:100) were purchased from Abcam. 
Secondary and third antibodies were obtained from Vector 
and Sigma respectively. 
  They were fixed by 4% paraformaldehyde, dehydrated, 
transparentized and paraffin embedded to obtain 4 毺m 
serial paraffin sections. Then slices were baked using an 
electrothermostat, xylene dewaxed to water and membrane 
rupture. Slices were heated by two changes of medium 
temperature, heat-induced microwave in solution of citrate 
buffer (pH 6.0) for 5 min, with pause duration for 3 min. 
Thereafter, all the slices were washed with PBS and added 
with 3% H2O2  to initiate the reaction away from light at room 
temperature for 30 min. They were washed again with PBS 
and the reaction started in the incubator at 37 曟 for 20 min 
with the diluted enzyme k (1:2 000). They were washed again, 
reacted in the incubator at 37 曟 for 30 min with 2% BSA; the 
slices were dried as much as possible to remove the liquid, 
then primary antibody was added. They were incubated for 
36 h at 4 曟 and equilibrated to room temperature for 2 h. 
They were washed again, added with secondary antibody 
and incubated at 37 曟 for 1 h. Then they were washed with 
PBS, added withSABC solution to co-incubate at 37 曟 for 
1 h. Remaining antibody was washed off, then they were 
developed with DAB for 8-10 min, redyed with hematoxylin, 
then the slides were dehydrated routinely until they became 
transparent. They were sealed with neutral resin. In negative 
control group the primary antibody was replaced with PBS, 
while in the positive control group the available HSP90 and 
HIF-1毩 positive colorectal cancer tissue slices were used. 
2.3. Evaluation criteria of the results 
  5 high-power fields were selected randomly in each slice, 
the percentages of positive tumor cells were: <10%, 0; 10%-
25%, 1; 26%-50%, 2; 51%-75%, 3; >75%, 4. Staining intensity 
scores were: 0 was into colorless, 1 was divided into weak 
(pale yellow), 2 was divided into medium (brown), 3 was 
classified as strong (tan). Finally, the percentages of positive 
tumor cells were multiplied by the staining intensity scores: 
≤2 was divided into negative and ≥3 was divided into 
positive. 
2.4. Statistical analysis 
  SPSS 12.0 software was used for statistical analysis of all the 
results, in which Spearman correlation test was adopted for 
correlation analysis and Chi-square test for data comparison 
between both groups. P<0.05 was considered as statistical 
significant difference. 
3. Results
3.1. Expression percentages of HSP90 and HIF-1毩 in 
colorectal cancer tissues and normal tissues   
  HSP90 was mainly expressed in the cytoplasm and nuclei of 
tumor cells as brown particles (Figure 1A), with the positive 
percentages in the normal tissues were significantly lower 
than those in the colorectal cancer tissues (30.0% vs. 63.0%) 
(氈
2 =6.110, P=0.013) (Table 1). The amount of HIF-1毩
expressed in the cytoplasm and/or nuclei was highest, 
and appeared as brown particles (Figure 1B). The positive 
percentages of HIF-1毩 in the colorectal cancer tissues were 
15.0% and 71.7% respectively, with statistical significant 
difference (氈
2 =18.100, P<0.001) (Table 1).
A                                                                        B
Figure 1. Expressions in colorectal cancer tissues (SABC method, 
magnification 400 times).
A: HSP90; B: HIF-1毩.
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Table 1




+ - + -
Normal tissues 20 6 3 17 14
Colorectal tissues 46 29 33 13 17
  
3.2. Expressions of HPS90 and HIF-1毩 in colorectal cancer 
and their respective correlations with the clinicopathologic 
features of colorectal cancer   
  There was no correlation of HSP90 expressions with 
patients’ sex, age, site of tumor without statistical 
significances (P>0.05). We found that HSP90 expressions 
were related with tumor differentiated degree, Dukes staging 
and lymph nodes metastasis with statistical significances 
(P<0.05), which were in line with the results from Dong 
Xing et al[6-8]. Also, there was no correlations of HIF-1毩 
expressions with patients’ sex, age, site of tumor without 
statistical significances (P>0.05). We found that HSP90 
expressions were related with Dukes staging and lymph 
nodes metastasis with statistical significances (P<0.05), 
which coincided with the results from Yoshimura et al[1,9] 
(Table 2)
3.3. Correlation of HSP90 and HIF-1毩 expressions in 
colorectal cancer tissues  
  There were 25 cases with positive HSP90 and HIF-1毩,
9 cases with negative HSP90 and HIF-1毩. Eight positive 
HIF-a cases showed negative HSP90 result; while 9 positive 
HSP90 cases showed negative HIF-1毩 result. Spearman 
correlation test showed that a positive correlation between 
HSP90 and HIF-1毩 in colorectal cancer tissues (毭=0.420, 
P<0.01).
4. Discussion
  The occurrence, development, metastasis and invasion 
of neoplams are result from interactions among polygenes, 
multiple factors and multi-stages. 
  HSPs, also known as molecular chaperon is essential 
for regulating intracellular protein balance with highly 
conserved amino acid sequence. Its main functions include 
direct protein folding within the cytoplasm, endoplasmic 
reticulum and mitochondria and its transmission and 
intracellular localization, repair and degrade denatured 
proteins and refold the misfolded proteins to prevent 
misparing and accumulation of proteome. In addition, HSPs 
Table 2





2  P Positive (%) 氈
2  P
Sex Male 28 68.5 0.047 0.828 67.9 0.532 0.466
Female 18 61.1 77.8
Age ≤60 22 68.2 0.478 0.489 68.2 0.263 0.608
＞60 24 58.3 75.0
Site of tumors Colon 25 56.0 1.166 0.280 72.0 0.002 0.966
Rectum 21 71.4 71.4
Differentiation degree
H i g h  a n d  m e d i u m  d i f f e r e n t i a t e d 
adenocarcinoma
29 51.7 4.315  0.038* 79.3 1.323 0.250
poorly differentiated adenocarcinoma 17 82.4 58.8
DUKES staging Stage A+B 30 50.0 6.298  0.012* 60.0 4.316  0.038*
Stage C+D 16 87.5 93.8
Lymph nodes metastasis Yes 30 87.5 6.298  0.012* 93.8 4.316  0.038*
No 16 50.0 60.0
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involves in the final step of activations of several regulatory 
proteins in eukaryotic cells, the remolding of several 
macromolecular protein complexes which comprises the 
signal transduction, transcription, cell division and migrated 
and differentiated proteins. Furthermore, in the presence of 
stressors such as high temperature, heavy metal, hypoxia 
and acidosis, the content of HSPs will increase[10,11].
  Based on the molecular weight of HSPs, it can be classed 
into several types such as HSP110, 90 and 70[12]. HSP90 
which is mainly comprised of HSP90a and HSP90毬,
is a macromolecular protein with the molecular weight 
of 90KD, largest part of which  exists in GRP94 of the 
endoplasmic reticulum (glucose regulated protein 94) 
and TRAP1 of the mitochondria (TNF receptor regulating 
protein)[13]. Under physiological status, HSP90 accounts for 
1% to 2% total proteins in cells; while in a state of stress, 
its content increased by about 2 to 10 times[6,10,11]. It has 
been demonstrated in previous studies that, the expression 
levels of HSPs in several solid tumors (breast cancer[10], 
hepatocellular carcinoma[14], gastric cancer, nasopharynx 
cancer and ovarian cancer[15,16]) and hematological 
malignancies have been increased[10].
  The  ta rge t  p ro te ins  o f  HSP 9 0  inc lude  mat r ix 
metalloproteinase 2 and urokinase involving in the process 
of tumor cells invasion and metastasis, hypoxia-inducible 
factor (HIF) that maintains revascularization, epidermal 
growth factor receptor (rEFGR), steroid receptor coactivator 
and etc[11,13], which play a role by regulating the function 
of protein kinase B, tumor necrosis factor receptor, nuclear 
factor 毷B to inhibit the apoptosis of tumor cells. Researches 
have shown that the expression levels of HSP complex in 
colon cancer are correlated with proliferating cell nuclear 
antigen, considering HSP complex may contributes to the 
rapid proliferation of tumor cells[7,11]. In our study, the 
positive percentages of HSP90 in normal and colorectal 
adenocacinoma tissues were 30% and 63%, respectively, 
with statistical significance. Therefore, the apparently 
higher expression levels of HSP90 in colorectal cancer 
tissues than those in the normal tissues indicates that 
the existing stressors such as hypoxia and acidosis at the 
beginning of colorectal cancer formation may contribute to 
the statistically higher HSP90 expression level in colorectal 
cancer tissues than those in the normal tissues. Meanwhile, 
it is demonstrated that there are statistical differences 
between both groups in the expressions and differentiation 
degree of HSP90, Dukes staging and their relationship with 
lymph nodes metastasis (P<0.05), which indicate that HSP90 
not only forms at the early stage of colorectal cancer, but 
also involves in several processes such as differentiation, 
invasion and metastasis. 
  HIF-1, a transcriptional activator of basic helix-loop-helix/
PER-ARNT-SIM, is comprised of HIF-1毬 and inducible 
expressed HIF-1毩. The continuous expression of HIF-1毬 
is not effected by the environment. As the major regulating 
component, the content of HIF-1毩 may be increased by 
several approaches like hypoxia and genetic variation[4,17-
19]. Higher expressions of several types of tumors like colon, 
breast, gastric, lung, skin, ovarian, pancreatic, prostate and 
renal carcinoma can be observed[20].
  As a transcriptional activator, HIF-1毩 involves in 
the gene coding procedures of 13 different glucose 
transporters, glycolytic enzymes and VEGF, as well as 
the coding of erythrogenin, transferrin, endothelin-1, 
inducible synthetase, hemeoxyganase 1, IGF-2, IGF binding 
protein 2 and 3, where most of the proteins are related to 
the occurrence and development of tumors[3,20].  In our 
study, the positive percentages of HIF-1毩 in normal and 
colorectal cancer tissues are 15.0% and 71.7%, respectively 
with statistical significance (P<0.05). Along with previous 
study observations that high expression levels of HIF-1毩 
in noncancerous lesions like colonic adenoma and prostatic 
intraepithelial neoplasia[20-22], it can be manifested that the 
increased levels of HIF-1毩 expression may be the results 
of the higher expressions of several genes that facilitate 
the occurrence and development of tumors, thus provide 
advantageous environment for the occurrence of colorectal 
cancer. In addition, HIF-1毩 can regulate and encode genes 
that play an important role in the pathophysiological process 
of cell invasion which including cathepsin D, MMP2, uro-
kinase-type plasminogen activator receptor, fibronectin 1, 
vimentin TGFa, autocrine motility factors, keratin 14, 18 and 
19. It has been verified that even if tissues experience an 
instant of hypoxia, the invasiveness of tumor cells towards 
basilar membrane in vitro also increase. While in our study, 
the expression of HIF-1毩 correlates with Dukes staging 
and lymph nodes metastasis with statistical significance 
(P<0.05), indicating HIF-1毩 may also participate in the 
gene regulation of proteins related to tumor metastasis and 
invasion and is essential for the invasion and metastasis of 
colorectal cancer.  
  According to the analysis of our results, there is a positive 
correlation between HSP90 and HIF-1毩 (r=0.420), with 
statistical significance (P<0.01), showing they may exert a 
synergistic effect on the occurrence, development, invasion 
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and metastasis of colorectal cancer. Therefore, it reminds 
us the combination of HSP90 and HIF-1毩 inhibitor may 
further improve the treatment efficacy of colorectal cancer. 
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